Foundation models for molecule design, customized for partners to enable novel, broadly accessible medicines
Drug discovery is slow and costly, limiting the development of novel and accessible medicines.
It builds foundation models for molecule design that are customized for partners to accelerate and improve drug discovery.
Pharma and biotechnology companies and research partners developing new therapeutics.



